Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001346824-26-000066·Bicara Therapeutics Inc.
Schedule 13D ownership disclosure
Bicara Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 055477103
Event date: 2026-02-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.Reported CIK 0001346824
Shares: 7,279,739.00 · Class: 11.5%
- Peter KolchinskyReported CIK 0001384859
Shares: 7,279,739.00 · Class: 11.5%
- Rajeev ShahReported CIK 0001619841
Shares: 7,279,739.00 · Class: 11.5%
- RA Capital Healthcare Fund, L.P.Reported CIK 0001315082
Shares: 4,603,418.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-26-000066
- Form type
- SCHEDULE 13D/A
- Filer
- Bicara Therapeutics Inc.
- CIK
- CIK 2023658
- Filed
- Mar 02, 2026
- Reporting period
- Feb 26, 2026
- Description
- Schedule 13D beneficial ownership